| 000 | 01799 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516035527.0 | ||
| 264 | 0 | _c20110912 | |
| 008 | 201109s 0 0 fre d | ||
| 022 | _a0151-9638 | ||
| 024 | 7 |
_a10.1016/j.annder.2011.02.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDellestable, P | |
| 245 | 0 | 0 |
_a[Impact of whole body magnetic resonance imaging (MRI) in the management of melanoma patients, in comparison with positron emission tomography/computed tomography (TEP/CT) and CT]. _h[electronic resource] |
| 260 |
_bAnnales de dermatologie et de venereologie _cMay 2011 |
||
| 300 |
_a377-83 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 | _aFalse Negative Reactions |
| 650 | 0 | 4 | _aFalse Positive Reactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdiagnostic imaging |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Staging _xmethods |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRadiotherapy |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aWhole Body Imaging |
| 700 | 1 | _aGranel-Brocard, F | |
| 700 | 1 | _aRat, A-C | |
| 700 | 1 | _aOlivier, P | |
| 700 | 1 | _aRégent, D | |
| 700 | 1 | _aSchmutz, J-L | |
| 773 | 0 |
_tAnnales de dermatologie et de venereologie _gvol. 138 _gno. 5 _gp. 377-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.annder.2011.02.023 _zAvailable from publisher's website |
| 999 |
_c20833201 _d20833201 |
||